In an interview with CNN, Alison Edelman, M.D., M.P.H. warns of the impacts of a widespread ban on mifepristone, a common medication used to end early pregnancy, approved for use by the FDA for over 20 years: “We have our gold standard of what we provide – the safest, most effective regimen – and then if it’s not available, we use the next best one. And that’s what we would be left with.”

A new study led by Jane Zhu, M.D., suggests Medicaid reimbursement for the same mental health treatment varies dramatically among U.S. states. Zhu says: “Our study confirms that some states are setting these reimbursement rates quite low, which has implications not just for provider acceptance of Medicaid insurance but also the extent to which they see Medicaid patients."

Ben Hoffman, M.D., offers advice on how to talk with kids about school shootings.

In an American College of Surgeons article on a cancer patient's journey, Susan Hedlund, M.S.W., says: “Many of the challenges that we face have historical roots. I believe it’s vital in medicine to understand these issues so we can really take a look at access, trust, and physical differences in care as well."

OHSU experts are included in highlights of the upcoming American Association for Cancer Research (AACR) annual meeting.

A Contagion Live article references work led by Brian Chan, M.D., M.P.H., that assessed hepatitis c virus screening disparities in adults served by community health centers by ethnicity and language preference.

A Becker's Hospital Review round-up lists includes Elizabeth Munro, M.D., Eneida Nemecek, M.D., M.B.A., Linda Stork, M.D., and Tanja Pejovic, M.D., among their list of "exceptional women in oncology."

OHSU signs a $111 million contract amendment with Skanska USA for its hospital expansion project.

A 2022 study led by OHSU researchers is cited in a Vox story on the current shortage of the drug addreall, used to treat attention-deficit hyperactivity disorders.

A new study led by Jane Zhu, M.D., suggests Medicaid reimbursement for the same mental health treatment varies dramatically among U.S. states. Zhu says: “Our study confirms that some states are setting these reimbursement rates quite low, which has implications not just for provider acceptance of Medicaid insurance but also the extent to which they see Medicaid patients."